Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma

... inflammatory tumor microenvironment, suggesting that BAP1 status might identify PeM, and possibly PlM, patients who would benefit from ICI therapy. Read more https://ift.tt/2UWp38D